Guardian Pharmacy Services, Inc. (NYSE:GRDN – Get Free Report) Director Steven D. Cosler acquired 7,000 shares of the stock in a transaction dated Tuesday, November 19th. The stock was bought at an average price of $21.22 per share, with a total value of $148,540.00. Following the purchase, the director now directly owns 17,713 shares in the company, valued at $375,869.86. This represents a 65.34 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Guardian Pharmacy Services Stock Performance
NYSE:GRDN opened at $21.28 on Thursday. Guardian Pharmacy Services, Inc. has a one year low of $14.16 and a one year high of $23.05.
Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last issued its quarterly earnings data on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The business had revenue of $314.39 million during the quarter, compared to analysts’ expectations of $303.21 million. As a group, sell-side analysts expect that Guardian Pharmacy Services, Inc. will post 0.86 EPS for the current fiscal year.
Analyst Ratings Changes
View Our Latest Research Report on GRDN
Hedge Funds Weigh In On Guardian Pharmacy Services
A number of hedge funds have recently bought and sold shares of the company. Wellington Management Group LLP bought a new position in shares of Guardian Pharmacy Services in the third quarter valued at approximately $8,400,000. Allspring Global Investments Holdings LLC purchased a new position in Guardian Pharmacy Services in the third quarter worth $5,460,000. Maven Securities LTD purchased a new position in Guardian Pharmacy Services in the third quarter worth $3,033,000. Seven Grand Managers LLC bought a new position in Guardian Pharmacy Services in the 3rd quarter valued at $2,515,000. Finally, Foundry Partners LLC purchased a new stake in shares of Guardian Pharmacy Services during the 3rd quarter valued at $1,680,000.
Guardian Pharmacy Services Company Profile
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Featured Stories
- Five stocks we like better than Guardian Pharmacy Services
- Consumer Discretionary Stocks Explained
- NVIDIA Growth Slows: So What? The Uptrend Will Continue
- Ride Out The Recession With These Dividend Kings
- Medtronic: A Dividend Aristocrat Powering Up for 2025 and Beyond
- 10 Best Airline Stocks to Buy
- Robinhood’s 330% Surge: Sustainable Rally or Bull Market Mirage?
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.